https://www.asx.com.au/asxpdf/20190131/pdf/442710lznc2kjl.pdf
- record revenue
- cash burn to slow as integration and compliance hurdles complete
- platform elements to commence commercial exposure in the US (April)
- business confidence shown by Management converting options
- $7.5M cash left
- Zuellig JV to kick off in Asia
I’ll be hanging around to see what the international aspirations with PDX and Zuellig does to revenue. US and Asian healthcare markets are huge.
Ann: MedAdvisor Quarterly Report & Appendix 4C, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
